Jason Kolbert is ranked #936 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Jason Kolbert

Q: How accurate are Jason Kolbert's stock ratings?

About 25% of Jason's ratings were profitable over a one-year hold, with an average return of -8.2% per rating, measured by 13Foresight from historical prices.

D. Boral Capital

Wall Street Analyst

★★★★☆

#936

on 13Foresight · ranked by our own returns

25%

Success Rate

-7.9%

Average Return

19 of 76 calls profitable · -23.2% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

📈 Across the calls we could measure, roughly 25% of Jason Kolbert's ratings turned a profit when each position was held for 1 year — averaging -7.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

11 Buy 14 Hold 0 Sell

Jason's Stock Coverage 132 ratings · 2026-10-11

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return	vs S&P 500 ⓘ
CANF Can-Fite BioPharma	May 13, 2026	BUY	Strong Buy +168.1% avg upside 8 analysts	$7.00 268.44% Upside	-47.8%	·
PRLD Prelude Therapeutics	May 04, 2026	BUY	Buy +179.1% avg upside 7 analysts	$9.00 131.35% Upside	-18.1%	·
VNRX VolitionRX	Apr 20, 2026	HOLD	Strong Buy +4573.5% avg upside 11 analysts	—	-93.4%	·
BEAT HeartBeam	Apr 20, 2026	HOLD	Buy +755.9% avg upside 14 analysts	—	-47.6%	·
NRXP NRX Pharmaceuticals	Apr 20, 2026	BUY	Strong Buy +1219.3% avg upside 5 analysts	$34.00 1092.94% Upside	-10.9%	·
IMUX Immunic	Apr 15, 2026	HOLD	Strong Buy +369.1% avg upside 22 analysts	—	-26.2%	·
CNSY Cerenome	Mar 31, 2026	HOLD	Strong Buy +1350.8% avg upside 11 analysts	—	-59.0%	·
FBLG FibroBiologics, Inc.	Mar 26, 2026	HOLD	Buy +696.5% avg upside 4 analysts	—	-73.2%	·
FATN Fatpipe, Inc.	Mar 23, 2026	BUY	Strong Buy +79.9% avg upside 3 analysts	$8.00 54.21% Upside	+166.2%	·
RVPH Reviva Pharmaceuticals Holdings	Mar 05, 2026	HOLD	Strong Buy +8693.9% avg upside 9 analysts	—	-88.2%	·
TVGN Tevogen Bio Holdings	Mar 04, 2026	HOLD	Buy -56.5% avg upside 2 analysts	—	-27.1%	·
GOVX GeoVax Labs	Feb 19, 2026	HOLD	Strong Buy +27480.1% avg upside 5 analysts	—	-82.0%	·
CLGN Collplant Holdings	Feb 06, 2026	HOLD	Strong Buy +380.8% avg upside 3 analysts	—	·	·
QNCX Quince Therapeutics	Jan 30, 2026	HOLD	Buy +454.5% avg upside 19 analysts	—	·	·
TTRX Turn Therapeutics Inc	Dec 29, 2025	BUY	Strong Buy +16.6% avg upside 3 analysts	$8.00 33.39% Downside	+282.2%	·
OMER Omeros	Dec 24, 2025	BUY	Sell +5.9% avg upside 14 analysts	$36.00 81.49% Upside	+29.1%	·
IVVD Invivyd	Nov 25, 2025	HOLD	Buy +1022.0% avg upside 8 analysts	—	-68.2%	·
ENLV Enlivex	Nov 24, 2025	HOLD	Strong Buy +16566.7% avg upside 4 analysts	—	·	·
CERO CERo Therapeutics Holdings	Nov 18, 2025	HOLD	Hold +1023.7% avg upside 2 analysts	—	-85.2%	·
BMEA Biomea Fusion	Nov 05, 2025	BUY	Strong Buy +815.5% avg upside 16 analysts	$12.00 745.08% Upside	-1.5%	·
CRMD Cormedix	Oct 20, 2025	BUY	Strong Buy +103.9% avg upside 13 analysts	$14.00 89.64% Upside	-40.1%	·
MSAI Multisensor AI Holdings	Oct 17, 2025	BUY	Strong Buy -2.7% avg upside 3 analysts	$3.00 35.49% Downside	-77.2%	·
AREC American Resources	Sep 15, 2025	BUY	Strong Buy +261.6% avg upside 7 analysts	$6.00 277.28% Upside	-14.6%	·
VERI Veritone	Sep 09, 2025	BUY	Strong Buy +1590.5% avg upside 14 analysts	$26.00 4601.58% Upside	-77.7%	·
ARTL Artelo Biosciences	Sep 08, 2025	HOLD	Hold 2 analysts	—	·	·
RCEL Avita Medical	Sep 05, 2025	BUY	Strong Buy -5.5% avg upside 11 analysts	$14.00 5.97% Upside	+162.9%	·
EVTL Vertical Aerospace	Aug 28, 2025	BUY	Strong Buy +1828.0% avg upside 10 analysts	$15.00 2772.46% Upside	-86.7%	·
CRVO CervoMed	Aug 18, 2025	BUY	Strong Buy +472.3% avg upside 9 analysts	$31.00 862.67% Upside	-73.5%	·
XAIR Beyond Air	Jul 17, 2025	BUY	Strong Buy +3792.1% avg upside 11 analysts	$11.00 388.82% Upside	·	·
URGN Urogen Pharma	Jun 12, 2025	BUY	Strong Buy +26.5% avg upside 16 analysts	$25.00 32.16% Downside	+168.2%	·
CTXR Citius Pharmaceuticals	Jun 10, 2025	BUY	Strong Buy +901.2% avg upside 3 analysts	$6.00 1101.47% Upside	-47.8%	·
NNOX Nano-X Imaging	May 23, 2025	BUY	Strong Buy +1620.0% avg upside 7 analysts	$10.00 1759.39% Upside	-64.1%	·
IMNM Immunome	May 19, 2025	HOLD	Strong Buy +68.8% avg upside 18 analysts	—	+145.4%	·
IMNN Imunon	May 19, 2025	HOLD	Strong Buy +1252.5% avg upside 11 analysts	—	-63.6%	·
MDCX Medicus Pharma Ltd	May 12, 2025	BUY	Strong Buy +10636.6% avg upside 6 analysts	$27.00 29215.88% Upside	-93.5%	·
NRSN Neurosense Therapeutics Ltd.	May 12, 2025	BUY	Strong Buy +2659.6% avg upside 5 analysts	$14.00 282.56% Upside	-24.3%	·
SCLX Scilex Holding Company	Apr 11, 2025	HOLD	Strong Buy +11287.0% avg upside 5 analysts	—	-0.9%	·
CARM Carisma Therapeutics	Apr 01, 2025	BUY	Hold +584900.0% avg upside 11 analysts	$1.00 199900.07% Upside	-85.5%	·
HUMA Humacyte	Mar 26, 2025	BUY	Strong Buy +1554.9% avg upside 11 analysts	$25.00 6068.21% Upside	-61.1%	·
LUNG Pulmonx	Mar 10, 2025	BUY	Strong Buy +296.6% avg upside 9 analysts	$17.00 823.95% Upside	-75.3%	·
ESLA Estrella Immunopharma	Feb 18, 2025	BUY	Strong Buy +3802.4% avg upside 1 analyst	$16.00 3802.40% Upside	-13.2%	·
ANVS Annovis Bio	Feb 10, 2025	HOLD	Buy +1730.0% avg upside 8 analysts	—	-12.4%	·
RKTO Rocket One	Jan 07, 2025	BUY	Strong Buy +1572.1% avg upside 8 analysts	$5.00 670.00% Upside	-54.4%	·
LCTX Lineage Therap	Jan 03, 2025	BUY	Strong Buy +455.9% avg upside 16 analysts	$2.00 101.12% Upside	+178.0%	·
CTSO Cytosorbents	Jan 03, 2025	BUY	Strong Buy +247.8% avg upside 13 analysts	$10.00 163.88% Upside	·	·
COYA Coya Therapeutics, Inc.	Dec 04, 2024	BUY	Strong Buy +223.2% avg upside 7 analysts	$15.00 202.96% Upside	-1.5%	·
MNOV Medicinova	Dec 02, 2024	BUY	Strong Buy +371.5% avg upside 6 analysts	$9.00 492.04% Upside	-38.2%	·
CNTX Context Therapeutics	Nov 25, 2024	BUY	Strong Buy +1625.8% avg upside 12 analysts	$9.00 2858.63% Upside	-23.3%	·
IBRX ImmunityBio	Oct 23, 2024	BUY	Buy +6.9% avg upside 12 analysts	$30.00 185.47% Upside	-30.9%	·
KAPA Kairos Pharma, Ltd.	Oct 14, 2024	BUY	Strong Buy +3571.5% avg upside 4 analysts	$9.00 1010.74% Upside	·	·
TRVI Trevi Therapeutics	Oct 04, 2024	BUY	Strong Buy +80.0% avg upside 18 analysts	$21.00 59.23% Upside	+227.2%	·
CLNN Clene	Sep 10, 2024	BUY	Strong Buy +744.6% avg upside 11 analysts	$23.00 495.95% Upside	+11.2%	·
OSTX OS Therapies Incorporated	Sep 03, 2024	BUY	Strong Buy +591.2% avg upside 5 analysts	$21.00 1196.31% Upside	-47.0%	·
ANIX Anixa Biosciences	Aug 07, 2024	BUY	Strong Buy +244.8% avg upside 4 analysts	$10.00 244.83% Upside	-0.3%	·
AVXL Anavex Life Sciences	Jul 22, 2024	BUY	Buy +1516.3% avg upside 9 analysts	$46.00 2987.33% Upside	+89.0%	·
USBC USBC	Mar 05, 2024	HOLD	Buy +96.2% avg upside 2 analysts	—	·	·
TNXP Tonix Pharma	Feb 28, 2024	BUY	Strong Buy +281.3% avg upside 8 analysts	$3.00 58.88% Downside	·	·
ZOMDF Zomedica	Nov 14, 2023	HOLD	Buy +1354.4% avg upside 3 analysts	—	-19.8%	·
FBIO Fortress Biotech	Nov 13, 2023	BUY	Strong Buy +270.1% avg upside 12 analysts	$10.00 368.39% Upside	+23.1%	·
DARE Daré Bioscience	Aug 30, 2023	BUY	Strong Buy +1635.0% avg upside 14 analysts	$24.00 3003.13% Upside	-58.0%	·
GNPX Genprex	Aug 22, 2023	HOLD	Strong Buy +175.8% avg upside 5 analysts	—	·	·
BJDX Bluejay Diagnostics	Aug 01, 2023	HOLD	Hold 1 analyst	—	·	·
CNTN Canton Strategic Holdings	Jul 17, 2023	HOLD	Strong Buy +2080.1% avg upside 3 analysts	—	·	·
SRNE Sorrento Therapeutics	Feb 13, 2023	HOLD	Strong Buy +3124900.0% avg upside 7 analysts	—	·	·
CETX Cemtrex	Feb 06, 2023	BUY	Strong Buy +528.0% avg upside 2 analysts	$23.00 1022.04% Upside	·	·
SMFL Smart for Life, Inc.	Dec 19, 2022	HOLD	Hold 1 analyst	—	·	·
HURA TuHURA Biosciences	Nov 18, 2022	HOLD	Strong Buy +368.9% avg upside 8 analysts	—	·	·
BCDA BioCardia	Nov 11, 2022	HOLD	Strong Buy +1390.4% avg upside 5 analysts	—	·	·
ATXI Avenue Therapeutics	Oct 07, 2022	BUY	Hold +4088.0% avg upside 4 analysts	$24.00 5484.03% Upside	·	·
ADTX Aditxt	Sep 16, 2022	BUY	Strong Buy +2033233.3% avg upside 2 analysts	—	·	·
MBAI MBody AI Ltd	Sep 15, 2022	HOLD	Strong Buy +168.8% avg upside 6 analysts	—	-44.8%	·
ALAR Alarum Technologies	Aug 31, 2022	BUY	Strong Buy +596.2% avg upside 3 analysts	$6.00 279.83% Upside	-42.4%	·
MESO Mesoblast	Aug 08, 2022	HOLD	Strong Buy +76.9% avg upside 14 analysts	—	-60.7%	·
MSB Mesabi Shs	Aug 08, 2022	HOLD	Hold 1 analyst	—	-30.9%	·
LSTA Lisata Therapeutics	Aug 05, 2022	HOLD	Buy +1121.7% avg upside 11 analysts	—	-58.0%	·
SNGX Soligenix	Jul 26, 2022	HOLD	Buy +807.6% avg upside 6 analysts	—	·	·
PRPH Prophase Labs	Jul 21, 2022	SELL	Sell 2 analysts	—	·	·
DYAI Dyadic International	Jul 18, 2022	HOLD	Buy +800.6% avg upside 3 analysts	—	-31.3%	·
PLUR Pluri	Jul 13, 2022	HOLD	Strong Buy +525.5% avg upside 8 analysts	—	-28.3%	·
BACK Imac Holdings	Jun 27, 2022	HOLD	Buy +833233.4% avg upside 3 analysts	—	·	·
ONCSQ OncoSec Medical	Jun 23, 2022	BUY	Strong Buy +4699999900.0% avg upside 9 analysts	$220.00 21999999899.93% Upside	·	·
ATHXQ Athersys	Jun 16, 2022	BUY	Buy +2996428471.4% avg upside 8 analysts	$175.00 17499999900.06% Upside	·	·
BCLI Brainstorm Cell Therapeutics	May 25, 2022	HOLD	Hold +321.3% avg upside 2 analysts	$4.00 321.35% Upside	·	·
CATX Perspective Therapeutics	May 11, 2022	HOLD	Strong Buy +315.1% avg upside 24 analysts	—	+140.7%	·
G Genpact	Apr 14, 2022	HOLD	Strong Buy +11.8% avg upside 22 analysts	—	+9.0%	·
GRDX GridAI Technologies	Mar 01, 2022	HOLD	Strong Buy +307.5% avg upside 7 analysts	—	·	·
BYSI Beyondspring	Jan 03, 2022	HOLD	Strong Buy +1231.3% avg upside 8 analysts	—	-65.1%	·
NTRP NextTrip	Jul 29, 2020	BUY	Buy +189.8% avg upside 4 analysts	$5.00 141.52% Upside	·	·
ADMA ADMA Biologics	Apr 17, 2020	HOLD	Strong Buy +5.8% avg upside 15 analysts	—	-38.7%	·
JAGX Jaguar Animal Health	Apr 17, 2020	HOLD	Strong Buy -2.1% avg upside 5 analysts	—	·	·
EMMA Emmaus Life Sciences	Sep 24, 2019	HOLD	Hold 2 analysts	—	·	·
ERNA Eterna Therapeutics	Feb 07, 2019	BUY	Strong Buy +2900.0% avg upside 4 analysts	$6.00 150.03% Upside	·	·
CHRS Coherus Biosciences	Nov 09, 2018	BUY	Buy +1056.3% avg upside 18 analysts	$28.00 2516.87% Upside	+89.6%	·
ATOS Atossa Therapeutics	Mar 22, 2018	BUY	Buy +563.9% avg upside 7 analysts	$24.00 883.60% Upside	·	·
SINT Sintx Technologies	Mar 06, 2018	HOLD	Buy +289.2% avg upside 8 analysts	—	·	·
SNOA Sonoma Pharmaceuticals	Mar 05, 2018	HOLD	Buy +1634.4% avg upside 4 analysts	$7.00 469.05% Upside	·	·
TRAW Traws Pharma	Mar 05, 2018	HOLD	Strong Buy +6975.5% avg upside 10 analysts	—	·	·
CRDF Cardiff Oncology	Mar 05, 2018	HOLD	Strong Buy +882.9% avg upside 18 analysts	—	·	·
ONC BeOne Medicines	Mar 01, 2018	BUY	Strong Buy +2.7% avg upside 28 analysts	$160.00 54.91% Downside	+5.3%	·
MNKD MannKind	Feb 28, 2018	SELL	Buy +111.9% avg upside 22 analysts	$1.00 69.62% Downside	+38.9%	·
IPCIQ IntelliPharmaCeutics International	Feb 16, 2018	HOLD	Buy +1649999900.1% avg upside 4 analysts	—	·	·
IMMP Immutep	Feb 15, 2018	BUY	Strong Buy +246.7% avg upside 7 analysts	$5.00 37.73% Upside	+19.7%	·
INO Inovio Pharmaceuticals	Feb 15, 2018	BUY	Strong Buy +659.6% avg upside 19 analysts	$8.00 595.69% Upside	·	·
EOCN Eocene	Feb 14, 2018	HOLD	Hold +591.4% avg upside 13 analysts	—	·	·
IDXG Interpace Diagnostics Group	Feb 14, 2018	BUY	Strong Buy +99.3% avg upside 9 analysts	$3.00 50.04% Downside	-3.1%	·
HEPA Hepion Pharmaceuticals	Feb 13, 2018	HOLD	Strong Buy +40971.4% avg upside 9 analysts	$4.00 3233.38% Upside	·	·
GILD Gilead Sciences	Feb 07, 2018	BUY	Strong Buy -20.9% avg upside 66 analysts	$94.00 37.79% Downside	-16.1%	·
TSE:CSCI COSCIENS Biopharma	Jan 17, 2018	BUY	Strong Buy +80.8% avg upside 8 analysts	$5.70 40.49% Downside	·	·
ATNM Actinium Pharmaceuticals	Dec 11, 2017	BUY	Strong Buy +526.2% avg upside 11 analysts	$3.00 172.69% Upside	-36.2%	·
INDP Indaptus Therapeutics	Nov 20, 2017	BUY	Buy +3595.2% avg upside 6 analysts	$8.00 218.79% Upside	·	·
BVNRY Bavarian Nordic	Sep 15, 2017	HOLD	Strong Buy 3 analysts	—	·	·
SDEV Stablecoin Development Corp	Sep 07, 2017	HOLD	Buy -16.2% avg upside 7 analysts	—	·	·
HRGN Harvard Apparatus Regenerative Technology	Sep 07, 2017	HOLD	Hold 1 analyst	—	-43.2%	·
VTGN VistaGen Therapeutics	Sep 07, 2017	HOLD	Hold +1001.2% avg upside 8 analysts	—	·	·
CFRXQ ContraFect	Sep 07, 2017	HOLD	Buy +10969999900.0% avg upside 10 analysts	—	·	·
THMO ThermoGenesis Holdings	Sep 07, 2017	HOLD	Buy +7499900.0% avg upside 4 analysts	—	·	·
AGEN Agenus	Sep 07, 2017	HOLD	Buy +53.7% avg upside 19 analysts	—	·	·
FFR FF EAI Robotics Ecosystem Inc	Jul 05, 2017	HOLD	Strong Buy +511.1% avg upside 7 analysts	—	·	·
BLRX Bioline RX Ltd Sponsored ADR	May 18, 2017	BUY	Strong Buy +340.0% avg upside 6 analysts	$3.00 35.45% Upside	·	·
SLS SELLAS Life Sciences Group	Feb 02, 2017	HOLD	Strong Buy +490.6% avg upside 16 analysts	—	·	·
SVRA Savara	Aug 01, 2016	BUY	Buy +76.4% avg upside 17 analysts	$5.00 1.54% Upside	·	·
BPTH Bio-Path Holdings	Jun 28, 2016	BUY	Strong Buy +4149900.0% avg upside 6 analysts	$5.00 2499899.93% Upside	·	·
KPRX Kiora Pharmaceuticals	Jun 27, 2016	HOLD	Strong Buy +252.4% avg upside 6 analysts	—	·	·
MBOT Microbot Medical	May 31, 2016	HOLD	Strong Buy +484.1% avg upside 8 analysts	—	·	·
BNTC Benitec Biopharma	Feb 26, 2016	HOLD	Strong Buy +183.5% avg upside 14 analysts	—	·	·
EDSA Edesa Biotech	Nov 24, 2015	BUY	Strong Buy +214.6% avg upside 6 analysts	$17.00 384.41% Upside	·	·
ABUS Arbutus Biopharma	Jun 15, 2015	HOLD	Strong Buy +109.3% avg upside 15 analysts	$14.00 231.80% Upside	-78.4%	·
VCEL Vericel	Mar 24, 2015	HOLD	Strong Buy +15.3% avg upside 16 analysts	—	+57.9%	·
VRTX Vertex Pharmaceuticals	Mar 24, 2015	HOLD	Strong Buy -13.6% avg upside 62 analysts	$121.00 76.36% Downside	-35.2%	·
PALI Palisade Bio	Mar 18, 2015	SELL	Strong Buy +1578.0% avg upside 16 analysts	$0.25 83.68% Downside	·	·
TOVX Theriva Biologics	Mar 16, 2015	HOLD	Strong Buy +3604.0% avg upside 8 analysts	$3.00 1282.53% Upside	·	·
IMUC ImmunoCellular Therapeutics	Mar 10, 2015	BUY	Strong Buy +3165.4% avg upside 3 analysts	$3.00 1681.07% Upside	·	·

🔒 127 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Jason Kolbert — Frequently Asked Questions

How accurate are Jason Kolbert's stock ratings?

Based on the calls 13Foresight could measure, about 25% of Jason's ratings were profitable over a one-year hold, with an average return of -8.2% per rating, or -142.3% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Jason ranked on 13Foresight?

Jason Kolbert is currently ranked #936 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Jason cover?

Jason most recently has ratings on CANF, PRLD, VNRX, BEAT, NRXP, IMUX, CNSY, FBLG, FATN, RVPH, TVGN, GOVX and 120 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Jason Kolbert

Rating Distribution

Welcome to 13Foresight!